RECKITT BENCKISER LLC v. AUROBINDO PHARMA LTD. , No. 17-1895 (Fed. Cir. 2018)

Annotate this Case

Download PDF

NOTE: This disposition is nonprecedential. United States Court of Appeals for the Federal Circuit ______________________ RECKITT BENCKISER LLC, Plaintiff-Appellant v. AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA INC., Defendants-Cross-Appellants ______________________ 2017-1895, 2018-1131 ______________________ Appeals from the United States District Court for the District of Delaware in No. 1:14-cv-01203-LPS, Chief Judge Leonard P. Stark. ______________________ JUDGMENT ______________________ DOUGLAS J. NASH, Barclay Damon, LLP, Syracuse, NY, argued for plaintiff-appellant. Also represented by LAURA VOGEL, Boston, MA; BELLA SATRA, Albany, NY. TIMOTHY KRATZ, Kratz & Barry LLP, Atlanta, GA, argued for defendants-cross-appellants. Also represented by GEORGE BARRY, III. _____________________ THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED: PER CURIAM (PROST, Chief Judge, MOORE and REYNA, Circuit Judges). AFFIRMED. See Fed. Cir. R. 36. ENTERED BY ORDER OF THE COURT September 10, 2018 Date /s/ Peter R. Marksteiner Peter R. Marksteiner Clerk of Court

Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.